Resistance to cefamandole: Derepression of f3-lactamases by cefoxitin and mutation in enterobacter cloacae

Thomas D. Gootz, Christine C. Sanders, Richard V. Goering

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their fJ-Iactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the fJ-Iactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for fJ-Iactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.

Original languageEnglish
Pages (from-to)34-42
Number of pages9
JournalJournal of Infectious Diseases
Volume146
Issue number1
DOIs
StatePublished - 1982

Fingerprint

Cefamandole
Enterobacter cloacae
Cefoxitin
Mutation
Isoelectric Focusing
Plasmids
Escherichia coli
Enzymes

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Immunology and Allergy
  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Resistance to cefamandole : Derepression of f3-lactamases by cefoxitin and mutation in enterobacter cloacae. / Gootz, Thomas D.; Sanders, Christine C.; Goering, Richard V.

In: Journal of Infectious Diseases, Vol. 146, No. 1, 1982, p. 34-42.

Research output: Contribution to journalArticle

@article{bbb01e844e86420b997057ff2caf4c40,
title = "Resistance to cefamandole: Derepression of f3-lactamases by cefoxitin and mutation in enterobacter cloacae",
abstract = "Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their fJ-Iactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the fJ-Iactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for fJ-Iactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.",
author = "Gootz, {Thomas D.} and Sanders, {Christine C.} and Goering, {Richard V.}",
year = "1982",
doi = "10.1093/infdis/146.1.34",
language = "English",
volume = "146",
pages = "34--42",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Resistance to cefamandole

T2 - Derepression of f3-lactamases by cefoxitin and mutation in enterobacter cloacae

AU - Gootz, Thomas D.

AU - Sanders, Christine C.

AU - Goering, Richard V.

PY - 1982

Y1 - 1982

N2 - Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their fJ-Iactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the fJ-Iactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for fJ-Iactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.

AB - Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their fJ-Iactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the fJ-Iactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for fJ-Iactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.

UR - http://www.scopus.com/inward/record.url?scp=0019954958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019954958&partnerID=8YFLogxK

U2 - 10.1093/infdis/146.1.34

DO - 10.1093/infdis/146.1.34

M3 - Article

C2 - 6979593

AN - SCOPUS:0019954958

VL - 146

SP - 34

EP - 42

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -